3 ms·
They could perhaps deny the application on the basis that the claimed benefits of the safety feature don't exist. https://www.law.cornell.edu/uscode/text/21/35
by maxerickson 10y ago
They could perhaps deny the application on the basis that the claimed benefits of the safety feature don't exist.
https://www.law.cornell.edu/uscode/text/21/355 https://www.law.cornell.edu/uscode/text/21/355
(5) evaluated on the basis of the information submitted to him as part of the application and any other information before him with respect to such drug, there is a lack of substantial evidence that the drug will have the effect it purports or is represented to have under the conditions of use prescribed, recommended, or suggested in the proposed labeling thereof; or (6) the application failed to contain the patent information prescribed by subsection
Maybe it's a stretch, but a marginally safer but much less accessible product actually doesn't improve the situation for the public.
I'm partly suggesting here that if the FDA doesn't have the authority, maybe they should.